Lilly Asia Ventures (LAV) has led a $50 million Series B round for Lynk Pharmaceuticals, a China-based drug developer that focuses on small-molecule treatments for autoimmune disease, inflammation, and cancer.
New Alliance Capital and Hangzhou Heda Industry Fund Investment came in as new investors, while Legend Capital and Med-Fine Capital re-upped. Lynk received tens of millions of US dollars in seed funding...
SoftBank Vision Fund 2 is the largest participant in a KRW223.6 billion ($187 million) investment in Naver Z, the metaverse platform unit of Korean internet giant Naver Corporation.
Horizons Ventures, the private investment arm of Hong Kong billionaire Li Ka-Shing, has led a A$129 million ($92.3 million) Series B round for Australia’s Harrison.ai, a clinical artificial intelligence (AI) developer.
Airbus Ventures has led a $25 million Series B round for Australia’s Q-Ctrl, a quantum computing developer increasingly geared toward space tech and orbital infrastructure.
STIC Investments has led a KRW1 trillion ($840 million) investment in Iljin Materials, a Korean producer of electric foils used in lithium batteries and consumer electronics, to support the international expansion of its manufacturing footprint.